bioMérieux

bioMérieux, established in 1963, is a pioneering leader in the field of in vitro diagnostics, dedicated to advancing health and safety across the globe. With over six decades of expertise, the company specializes in developing innovative diagnostic tests that are vital in managing various health conditions, including infectious diseases, antimicrobial resistance, and food safety. Their comprehensive product portfolio includes renowned solutions like BIOFIRE®, VITEK®, and ARGENE®, which are designed for use in hospitals, laboratories, and point-of-care settings.

Additionally, bioMérieux provides services catering to pharmaceutical quality control, environmental monitoring, and microbiological testing, ensuring safety in food and drug production. Committed to improving patient care, bioMérieux's diagnostic innovations not only support rapid and accurate disease detection but also guide effective treatment decisions. Through its continuous commitment to research and development, bioMérieux remains at the forefront of clinical diagnostics, contributing significantly to a healthier future